Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovarian surface epithelial cells of cladribine-treated rats

Protoplasma

Volumn 250, Issue 5, 2013, Pages 1025-1034

  Jedrych, Marian ^a   Wawryk Gawda, Ewelina ^a   Jodłowska Jedrych, Barbara ^a   Chylińska Wrzos, Patrycja ^a   Jasiński, Ludwik ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Internal Diseases Department   (Poland)

Author keywords

Apoptosis; Caspase 3; Cladribine; Ki 67; Ovarian surface epithelium

Indexed keywords

RATTUS;

ANTINEOPLASTIC AGENT; CLADRIBINE;

ANIMAL; APOPTOSIS; ARTICLE; CELL GROWTH; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; EPITHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; OVARY; PATHOLOGY; RANDOMIZATION; RAT; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL GROWTH PROCESSES; CLADRIBINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; IMMUNOHISTOCHEMISTRY; OVARY; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84884904873     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00709-012-0461-z     Document Type: Article

References (59)

1. Aichberger KJ, Sperr WR, Gleixner KV, Kretschmer A, Valent P (2008) Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis. Eur J Clin Invest 38(11): 869-873. doi: 10. 1111/j. 1365-2362. 2008. 02036. x.
2. Auersperg N, Maclaren IA, Kruk PA (1991) Ovarian surface epithelium: autonomous production of connective tissue-type extracellular matrix. Biol Reprod 44(4): 717-724. doi: 10. 1095/biolreprod44. 4. 717.
3. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22(2): 255-288. doi: 10. 1210/er. 22. 2. 255.
4. Bastin-Coyette L, Smal C, Cardoen S, Saussoy P, van den Neste E, Bontemps F (2008) Mechanisms of cell death induced by 2-chloroadenosine in leukemic B-cells. Biochem Pharmacol 1;75(7): 1451-1460.
5. Bernknopf A, Rowley K, Bailey T (2011) A review of systemic lupus erythematosus and current treatment options. Formulary 46: 178-194.
6. Ceruti S, Franceschi C, Barbieri D, Malorni W, Camurri A, Giammarioli AM, Ambrosini A, Racagni G, Cattabeni F, Abbracchio MP (2000) Apoptosis induced by 2-chloro-adenosine and 2-chloro-2'-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance. J Neurosci Res 1;60(3): 388-400. doi: 10. 1002/(SICI)1097-4547(20000501)60: 3<388:: AID-JNR14>3. 0. CO;2-V.
7. Ceruti S, Beltrami E, Matarrese P, Mazzola A, Cattabeni F, Malorni W, Abbracchio MP (2003) A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2'-deoxy-adenosine (cladribine) and 2-chloro-adenosine in human astrocytoma cells. Mol Pharmacol 63(6): 1437-1447. doi: 10. 1124/mol. 63. 6. 1437.
8. Chang HL, MacLaughlin DT, Donahoe PK (2008-2009) Somatic stem cells of the ovary and their relationship to human ovarian cancers. StemBook [Internet]. Harvard Stem Cell Institute, Cambridge. doi/10. 3824/stembook. 1. 43. 1.
9. Chene G, Penault-Llorca F, Tardieu A, Cayre A, Lagarde N, Jaffeux P, Aublet-Cuvelier B, Dechelotte P, Felloni B, Pouly JL, Dauplat J (2012) Is there a relationship between ovarian epithelial dysplasia and infertility? Obstet Gynecol Int. doi: 10. 1155/2012/429085.
10. Chmielewski M, Linke K, Zabel M (2008) Metody wykrywania zjawiska apoptozy w komórkach wa{ogonek}trobowych in situ. [Methods of detecting the phenomenon of apoptosis in liver cells in situ.]. [Article in Polish] Nowiny Lekarskie 3: 223-226.
11. - hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells. Leuk Lymphoma 43(2): 377-384.
12. Chow KU, Rummel MJ, Weidmann E, Ries J, Jantschke P, Boehrer S, Pourebrahim F, Napieralski S, Stein J, Martin H, Hoelzer D, Mitrou PS (2000) Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone. Leuk Lymphoma 36(5-6): 559-567. doi: 10. 3109/10428190009148404.
13. Chubar Y, Bennett M (2003) Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. Br J Haematol 122(5): 768-770.
14. Conrad DM, Robichaud MR, Mader JS, Boudreau RT, Richardson AM, Giacomantonio CA, Hoskin DW (2008) 2-Chloro-2'-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop. Int J Oncol 32(6): 1325-1333.
15. Corakci A, Filiz S, Caliskan E, Dalcik C, Ozeren S, Dalcik H (2005) The effects of ovulation induction on ovarian epithelium dysplasia scores and Ki67 expression: an experimental study on rats. Int J Gynecol Cancer 15(5): 866-871.
16. Dutta EJ, Habermann TM, Hoos GL, Weiler CR (2002) Treatment of idiopathic urticaria, angioedema and anaphylaxis with cladribine. J Allergy Clin Immunol 109(1): S335.
17. Eibschutz B, Baird SM, Weisman MH, Amox DG, Spellman M, Piacquadio D, Carrera CJ, Carson DA (1995) Oral 2-chlorodeoxyadenosine in psoriatic arthritis. A preliminary report. Arthritis Rheum 38(11): 1604-1609.
18. Galmarini CM, Voorzanger N, Falette N, Jordheim L, Cros E, Puisieux A, Dumontet C (2003) Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine. Biochem Pharmacol 1;65(1): 121-129.
19. Gava N, Clarke CL, Bye C, Byth K, deFazio A (2008) Global gene expression profiles of ovarian surface epithelial cells in vivo. J Mol Endocrinol 40(6): 281-296. doi: 10. 1677/JME-07-0149.
20. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4): 1710-1715.
21. Hartung HP (2009) New oral therapies may offer improved treatment options for patients with multiple sclerosis. Curr Opin Neurol 22: S10-S14.
22. Hassan R, Gupta M, Kern W, Ozer H (2004) Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature. Leuk Lymphoma 45(10): 2149-2152. doi: 10. 1080/10428190410001714070.
23. Inwards DJ, Fishkin PA, Hillman DW, Brown DW, Ansell SM, Kurtin PJ, Fonseca R, Morton RF, Veeder MH, Witzig TE (2008) Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group. Cancer 1;113(1): 108-116. doi: 10. 1002/cncr. 23537.
24. Johnston JB (2011) Mechanism of action of pentostatin and cladribine in hairy cell leukemia. Leuk Lymphoma 52(Suppl 2): 43-45. doi: 10. 3109/10428194. 2011. 570394.
25. King SM, Burdette JE (2011) Evaluating the progenitor cells of ovarian cancer: analysis of current animal models. BMB Rep 44(7): 435-445. doi: 10. 5483/BMBRep. 2011. 44. 7. 435.
26. Klöpfer A, Hasenjäger A, Belka C, Schulze-Osthoff K, Dörken B, Daniel PT (2004) Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway. Oncogene 23(58): 9408-9418. doi: 10. 1038/sj. onc. 1207975.
27. Korycka A (2008) Perspektywy leczniczego zastosowania nowych analogów nukleozydów purynowych [Perspectives of therapeutical application of new purine nucleoside analogues] Article in Polish. Acta Haematol Pol 39(4): 727-741.
28. Korycka A, Błoński JZ, Robak T (2007) Forodesine (BCX-1777, Immucillin H)-a new purine nucleoside analogue: mechanism of action and potential clinical application. Mini Rev Med Chem 7(9): 976-983.
29. Korzeniewska-Dyl I (2007) Kaspazy-struktura i funkcja [Caspases-structure and function] Article in Polish. Pol Merkur Lekarski 23(138): 403-407.
30. Laurencet FM, Zulian GB, Cabrol C, Betticher DC (1997) Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy. Cancer Genet Cytogenet 99(1): 85-89.
31. Lech-Marańda E, Korycka A, Robak T (2000) Influence of gemcitabine (2', 2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro. Eur J Haematol 65(5): 317-321. doi: 10. 1034/j. 1600-0609. 2000. 065005317. x.
32. Leist TP, Weissert R (2011) Cladribine: mode of action and implications for treatment of multiple sclerosis. Clin Neuropharmacol 34(1): 28-35. doi: 10. 1097/WNF. 0b013e318204cd90.
33. Liang L, Xu B, Zhu G (2009) Effect of repeated gonadotropin stimulation on ovarian reserves and proliferation of ovarian surface epithelium in mice. Front Med China 3(2): 220-226. doi: 10. 1007/s11684-009-0037-2.
34. Marczak A, Łubgan D, Robak T, Jóźwiak Z (2004) Influence of 2-chlorodeoxyadenosine (cladribine) on human erythrocytes. Int J Biochem Cell Biol 36(8): 1645-1654.
35. Martinelli G, Zinzani PL, Farabegoli P (1996) Purine analogs (fludarabine and 2-chlorodeoxyadenosine) as apoptosis-inducing drugs in CML therapy. Haematologica 81(3): 286-287.
36. Mottl H, Starý J, Chánová M, Nekolná M, Drahokoupilová E, Smelhaus V (2006) Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine. Leuk Lymphoma 47(9): 1881-1884. doi: 10. 1080/10428190600687281.
37. Murdoch WJ, McDonnel AC (2002) Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123(6): 743-750.
38. Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB (2003) Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem 51(12): 1681-1688. doi: 10. 1177/002215540305101212.
39. Nishida T, Nishida N (2006) Reinstatement of "germinal epithelium" of the ovary. Reprod Biol Endocrinol 4: 42. doi: 10. 1186/1477-7827-4-42.
40. Nomura Y, Inanami O, Takahashi K, Matsuda A, Kuwabara M (2000) 2-Chloro-2'-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4. Leukemia 14(2): 299-306.
41. Perez RP, Hamaguchi K, Tracey PA, Handel LM, Hamilton TC, Godwin AK (1993) Transformation of rat ovarian epithelial and Rat-1 fibroblast cell lines by RAST24 does not influence cisplatin sensitivity. Cancer Res 53(16): 3771-3775.
42. Petzer AL, Bilgeri R, Zilian U, Haun M, Geisen FH, Pragnell I, Braunsteiner H, Konwalinka G (1991) Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid, and T-lymphocytic colony growth. Blood 78(10): 2583-2587.
43. Robak T, Korycka A, Lech-Maranda E, Robak P (2009) Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases. Molecules 14(3): 1183-1226.
44. Rossini MS, de Souza EM, Cintra ML, Pagnano KB, Chiari AC, Lorand-Metze I (2004) Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol 18(5): 538-542. doi: 10. 1111/j. 1468-3083. 2004. 00969. x.
45. Rourke M, Anderson KC, Ghobrial IM (2010) Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients. Leuk Lymphoma 51(10): 1779-1792. doi: 10. 3109/10428194. 2010. 499977.
46. Saven A, Burian C, Koziol JA, Piro LD (1998) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 15;92(6): 1918-1926.
47. Schlette EJ, Admirand J, Wierda W, Abruzzo L, Lin KI, O'Brien S, Lerner S, Keating MJ, Tam C (2009) p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy. Leuk Lymphoma 50(10): 1597-1605.
48. Singavarapu R, Buchinsky N, Cheon DJ, Orsulic S (2010) Whole ovary immunohistochemistry for monitoring cell proliferation and ovulatory wound repair in the mouse. Reprod Biol Endocrinol 8: 98. doi: 10. 1186/1477-7827-8-98.
49. Slot KA, de Boer-Brouwer M, Voorendt M, Sie-Go DM, Ghahremani M, Dorrington JH, Teerds KJ (2006) Irregularly shaped inclusion cysts display increased expression of Ki67, Fas, Fas ligand, and procaspase-3 but relatively little active caspase-3. Int J Gynecol Cancer 16(1): 231-239.
50. Smal C, Lisart S, Maerevoet M, Ferrant A, Bontemps F, van Den Neste E (2007) Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-20-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB. Biochem Pharmacol 73: 351-358.
51. Spurgeon S, Yu M, Phillips JD, Epner EM (2009) Cladribine: not just another purine analogue? Expert Opin Investig Drugs 18(8): 1169-1181. doi: 10. 1517/13543780903071038.
52. Stewart SL, Querec TD, Gruver BN, O'Hare B, Babb JS, Patriotis C (2004) Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium. J Cell Physiol 198(1): 119-124. doi: 10. 1002/jcp. 10401.
53. Sznarkowska A, Olszewski R, Zawacka-Pankau J (2010) Farmakologiczna aktywacja supresora nowotworu, natywnego białka p53 jako obiecuja{ogonek}ca strategia zwalczania nowotworów [Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer] Article in Polish. Postepy Hig Med Dosw (Online) 64: 396-407.
54. Tawfik NM, Nasr AS (2011) Comparative study between intravenous and subcutaneous administration of cladribine in treatment of hairy cell leukemia patients. Comp Clin Pathol, Online First™.
55. Virant-Klun I, Skutella T, Stimpfel M, Sinkovec J (2011) Ovarian surface epithelium in patients with severe ovarian infertility: a potential source of cells expressing markers of pluripotent/multipotent stem cells. J Biomed Biotechnol 2011: 381928. doi: 10. 1155/2011/381928.
56. Vosoughi R, Freedman MS (2010) Therapy of MS. Clin Neurol Neurosurg 112(5): 365-385.
57. Wierzbowska A, Robak T, Pluta A, Wawrzyniak E, Cebula B, Hołowiecki J, Kyrcz-Krzemień S, Grosicki S, Giebel S, Skotnicki AB, Piatkowska-Jakubas B, Kuliczkowski K, Kiełbiński M, Zawilska K, Kłoczko J, Wrzesień-Kuś A, Polish Adult Leukemia Group (2008) Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group. Eur J Haematol 80(2): 115-126. doi: 10. 1111/j. 1600-0609. 2007. 00988. x.
58. Wubah JA, Ibrahim MM, Gao X, Nguyen D, Pisano MM, Knudsen TB (1996) Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr Biol 1;6(1): 60-69. doi: 10. 1016/S0960-9822(02)00422-0.
59. Wubah JA, Setzer RW, Lau C, Charlap JH, Knudsen TB (2001) Exposure-disease continuum for 2-chloro-2'-deoxyadenosine, a prototype ocular teratogen. 1. Dose-response analysis. Teratology 64(3): 154-169. doi: 10. 1002/tera. 1059.